Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
SURPASS y SURMOUNT El desarrollo clnico de tirzepatida ha contado con un robusto programa de ensayos clnicos, conocidos como SURPASS (en personas con DM2) y SURMOUNT (en personas con obesidad y sobrepeso, sin diabetes), en los que se ha demostrado el potente efecto de la molcula en cuanto a control glucmico, consiguiendo incluso la normalizacin de los niveles de HbA1c hasta en el 51% de las personas con DM2 tratadas, y prdidas de peso con descensos de alrededor del 20% con las dosis de 10 y 15 mg/semana en obesidad
This reduces caloric intake, drives weight loss, and triggers a cascade of metabolic improvements
Our Summerlin physicians determine which medication is right for you based on your health profile and goals
Based on investigational protocol reports and the clinical trial data, most subjects begin to see measurable changes in body composition at 4 to 6 weeks on a consistent daily protocol at 300 mcg
A basic stance may burn 100150 calories, while a full-body session can reach 200300 calories
Those with BMI of 27-29.9 accompanied by weight-related health conditions like type 2 diabetes, hypertension, or sleep apnea also fall within appropriate treatment parameters
US$ 23.02
US$ 25.89
US$ 21.96
US$ 29.11
US$ 23.82
US$ 20.95
US$ 29.49
US$ 20.91
US$ 28.71
